Defunct Company
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
90
NCT03911882
Efficacy and Tolerability of CELERGEN in Fibromyalgia
Phase: N/A
Role: Lead Sponsor
Start: Apr 29, 2016
Completion: Aug 30, 2016